Hassany Sahar M, Moustafa Ehab F Abdou, Taher Mohamed El, Abdeltwab Afaf Adel, Blum Hubert E
Sahar M Hassany, Ehab F Abdou Moustafa, Mohamed El Taher, Department of Tropical Medicine and Gastroenterology, Assiut University, Assiut 71526, Egypt.
World J Gastrointest Oncol. 2015 Sep 15;7(9):161-71. doi: 10.4251/wjgo.v7.i9.161.
To assess the practice of Egyptian physicians in screening patients for hepatocellular carcinoma (HCC).
The study included 154 physicians from all over Egypt caring for patients at risk for HCC. The study was based on a questionnaire with 20 items. Each questionnaire consisted of two parts: (1) personal information regarding the physician (name, age, specialty and type of health care setting); and (2) professional experience in the care of patients at risk for HCC development (screening, knowledge about the cause and natural course of liver diseases and HCC risk).
Sixty-eight percent of doctors with an MD degree, 48% of doctors with a master degree or a diploma and 40% of doctors with a Bachelor of Medicine, Bachelor of Surgery certificate considered the hepatitis C virus (HCV) genotype as risk factor for HCC development (P < 0.05). Ninety percent of physicians specialized in tropical medicine, internal medicine or gastroenterology and 67% of physicians in other specialties advise patients to undergo screening for HCV and hepatitis B virus infection as well as liver cirrhosis (P < 0.05). Eighty-six percent of doctors in University Hospitals and 69% of Ministry of Health (MOH) doctors consider HCV infection as the leading cause of HCC in Egypt (P < 0.05). Seventy-two percent of doctors with an MD degree, 55% of doctors with a master degree or a diploma, 56% of doctors with an MBBCH certificate, 74% of doctors in University Hospitals and 46% of MOH hospital doctors consider abdominal ultrasonography as the most important investigation in HCC screening (P < 0.05). Sixty-five percent of physicians in tropical medicine, internal medicine or gastroenterology and 37% of physicians in other specialties recommend as HCC screening interval of 3 mo (P < 0.05). Seventy-one percent of doctors with an MD degree, 50% of doctors with a master degree or diploma and 60% of doctors with an MBBCH certificate follow the same recommendation.
In Egypt, physicians specialized in tropical medicine, internal medicine or gastroenterology with an MD degree and working in a University Hospital are best informed about HCC.
评估埃及医生对肝细胞癌(HCC)患者进行筛查的实际情况。
该研究纳入了来自埃及各地的154名负责照顾HCC高危患者的医生。该研究基于一份包含20个条目的问卷。每份问卷由两部分组成:(1)医生的个人信息(姓名、年龄、专业和医疗保健机构类型);(2)在照顾HCC发生高危患者方面的专业经验(筛查、对肝脏疾病病因和自然病程以及HCC风险的了解)。
68%拥有医学博士学位的医生、48%拥有硕士学位或文凭的医生以及40%拥有医学学士和外科学士证书的医生认为丙型肝炎病毒(HCV)基因型是HCC发生的危险因素(P<0.05)。90%专门从事热带医学、内科或胃肠病学的医生以及67%其他专业的医生建议患者接受HCV和乙型肝炎病毒感染以及肝硬化的筛查(P<0.05)。86%大学医院的医生和69%卫生部(MOH)的医生认为HCV感染是埃及HCC的主要病因(P<0.05)。72%拥有医学博士学位的医生、55%拥有硕士学位或文凭的医生、56%拥有医学学士和外科学士证书的医生、74%大学医院的医生以及46%卫生部医院的医生认为腹部超声检查是HCC筛查中最重要的检查(P<0.05)。65%从事热带医学、内科或胃肠病学的医生以及37%其他专业的医生建议HCC筛查间隔为3个月(P<0.05)。71%拥有医学博士学位的医生、50%拥有硕士学位或文凭的医生以及60%拥有医学学士和外科学士证书的医生遵循相同的建议。
在埃及,拥有医学博士学位、在大学医院工作、专门从事热带医学、内科或胃肠病学的医生对HCC的了解最为充分。